{"id":"https://openalex.org/W4220831723","doi":"https://doi.org/10.1158/1538-7445.sabcs21-p2-12-07","title":"Abstract P2-12-07: Fdg PET/CT early response prediction for triple negative breast cancer neoadjuvant chemotherapy with addition of carboplatin","display_name":"Abstract P2-12-07: Fdg PET/CT early response prediction for triple negative breast cancer neoadjuvant chemotherapy with addition of carboplatin","publication_year":2022,"publication_date":"2022-02-15","ids":{"openalex":"https://openalex.org/W4220831723","doi":"https://doi.org/10.1158/1538-7445.sabcs21-p2-12-07"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs21-p2-12-07","doi":"https://doi.org/10.1158/1538-7445.sabcs21-p2-12-07","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs21-p2-12-07","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5041249091","display_name":"Marcin Kubeczko","orcid":"https://orcid.org/0000-0003-1877-5691","observed_orcids":["https://orcid.org/0000-0003-1877-5691"]},"institutions":[{"id":"https://openalex.org/I4210150880","display_name":"The Maria Sklodowska-Curie National Research Institute of Oncology","ror":"https://ror.org/04qcjsm24","country_code":"PL","type":"healthcare","lineage":["https://openalex.org/I4210150880"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Marcin Kubeczko","raw_affiliation_strings":["Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland","institution_ids":["https://openalex.org/I4210150880"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Anna Michalik","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150880","display_name":"The Maria Sklodowska-Curie National Research Institute of Oncology","ror":"https://ror.org/04qcjsm24","country_code":"PL","type":"healthcare","lineage":["https://openalex.org/I4210150880"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Anna Michalik","raw_affiliation_strings":["Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland","institution_ids":["https://openalex.org/I4210150880"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001127020","display_name":"Agnieszka Badora-Rybicka","orcid":"https://orcid.org/0000-0001-7064-0976","observed_orcids":["https://orcid.org/0000-0001-7064-0976"]},"institutions":[{"id":"https://openalex.org/I4210150880","display_name":"The Maria Sklodowska-Curie National Research Institute of Oncology","ror":"https://ror.org/04qcjsm24","country_code":"PL","type":"healthcare","lineage":["https://openalex.org/I4210150880"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Agnieszka Badora-Rybicka","raw_affiliation_strings":["Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland","institution_ids":["https://openalex.org/I4210150880"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060883938","display_name":"Anna Polakiewicz-Gilowska","orcid":"https://orcid.org/0000-0002-2175-7067","observed_orcids":["https://orcid.org/0000-0002-2175-7067"]},"institutions":[{"id":"https://openalex.org/I4210150880","display_name":"The Maria Sklodowska-Curie National Research Institute of Oncology","ror":"https://ror.org/04qcjsm24","country_code":"PL","type":"healthcare","lineage":["https://openalex.org/I4210150880"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Anna Polakiewicz-Gilowska","raw_affiliation_strings":["Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland","institution_ids":["https://openalex.org/I4210150880"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031424081","display_name":"Andrea d\u2019Amico","orcid":"https://orcid.org/0000-0003-4632-2139","observed_orcids":["https://orcid.org/0000-0003-4632-2139"]},"institutions":[{"id":"https://openalex.org/I4210150880","display_name":"The Maria Sklodowska-Curie National Research Institute of Oncology","ror":"https://ror.org/04qcjsm24","country_code":"PL","type":"healthcare","lineage":["https://openalex.org/I4210150880"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Andrea d'Amico","raw_affiliation_strings":["Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland","institution_ids":["https://openalex.org/I4210150880"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105988256","display_name":"Micha\u0142 Kalemba","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150880","display_name":"The Maria Sklodowska-Curie National Research Institute of Oncology","ror":"https://ror.org/04qcjsm24","country_code":"PL","type":"healthcare","lineage":["https://openalex.org/I4210150880"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Micha\u0142 Kalemba","raw_affiliation_strings":["Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland","institution_ids":["https://openalex.org/I4210150880"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055075238","display_name":"Aleksandra Le\u015bniak","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150880","display_name":"The Maria Sklodowska-Curie National Research Institute of Oncology","ror":"https://ror.org/04qcjsm24","country_code":"PL","type":"healthcare","lineage":["https://openalex.org/I4210150880"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Aleksandra Le\u015bniak","raw_affiliation_strings":["Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland","institution_ids":["https://openalex.org/I4210150880"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006827136","display_name":"K Swiderska","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150880","display_name":"The Maria Sklodowska-Curie National Research Institute of Oncology","ror":"https://ror.org/04qcjsm24","country_code":"PL","type":"healthcare","lineage":["https://openalex.org/I4210150880"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Katarzyna \u015awiderska","raw_affiliation_strings":["Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland","institution_ids":["https://openalex.org/I4210150880"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074751769","display_name":"Marta Mianowska-Malec","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150880","display_name":"The Maria Sklodowska-Curie National Research Institute of Oncology","ror":"https://ror.org/04qcjsm24","country_code":"PL","type":"healthcare","lineage":["https://openalex.org/I4210150880"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Marta Mianowska-Malec","raw_affiliation_strings":["Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland","institution_ids":["https://openalex.org/I4210150880"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081994701","display_name":"Agnieszka Pasierbek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150880","display_name":"The Maria Sklodowska-Curie National Research Institute of Oncology","ror":"https://ror.org/04qcjsm24","country_code":"PL","type":"healthcare","lineage":["https://openalex.org/I4210150880"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Agnieszka Pasierbek","raw_affiliation_strings":["Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland","institution_ids":["https://openalex.org/I4210150880"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113196362","display_name":"Barbara \u0141anoszka","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150880","display_name":"The Maria Sklodowska-Curie National Research Institute of Oncology","ror":"https://ror.org/04qcjsm24","country_code":"PL","type":"healthcare","lineage":["https://openalex.org/I4210150880"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Barbara \u0141anoszka","raw_affiliation_strings":["Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland","institution_ids":["https://openalex.org/I4210150880"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002959823","display_name":"Konstanty Chomik","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210150880","display_name":"The Maria Sklodowska-Curie National Research Institute of Oncology","ror":"https://ror.org/04qcjsm24","country_code":"PL","type":"healthcare","lineage":["https://openalex.org/I4210150880"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Konstanty Chomik","raw_affiliation_strings":["Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland","institution_ids":["https://openalex.org/I4210150880"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073154117","display_name":"Barbara Bobek\u2010Billewicz","orcid":"https://orcid.org/0000-0003-3262-9738","observed_orcids":["https://orcid.org/0000-0003-3262-9738"]},"institutions":[{"id":"https://openalex.org/I4210150880","display_name":"The Maria Sklodowska-Curie National Research Institute of Oncology","ror":"https://ror.org/04qcjsm24","country_code":"PL","type":"healthcare","lineage":["https://openalex.org/I4210150880"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Barbara Bobek-Billewicz","raw_affiliation_strings":["Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland","institution_ids":["https://openalex.org/I4210150880"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023706702","display_name":"Micha\u0142 Jarz\u0105b","orcid":"https://orcid.org/0000-0002-2642-9724","observed_orcids":["https://orcid.org/0000-0002-2642-9724"]},"institutions":[{"id":"https://openalex.org/I4210150880","display_name":"The Maria Sklodowska-Curie National Research Institute of Oncology","ror":"https://ror.org/04qcjsm24","country_code":"PL","type":"healthcare","lineage":["https://openalex.org/I4210150880"]}],"countries":["PL"],"is_corresponding":false,"raw_author_name":"Micha\u0142 Jarz\u0105b","raw_affiliation_strings":["Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Maria Sklodowska-Curie National Research Institute of Oncology, Gliwice, Poland","institution_ids":["https://openalex.org/I4210150880"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210150880"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"82","issue":"4_Supplement","first_page":"P2","last_page":"12"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.8051999807357788,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.8051999807357788,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10522","display_name":"Medical Imaging Techniques and Applications","score":0.13379999995231628,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11885","display_name":"MRI in cancer diagnosis","score":0.02669999934732914,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/triple-negative-breast-cancer","display_name":"triple-negative breast cancer","score":0.9950000047683716},{"id":"https://openalex.org/keywords/neoadjuvant-chemotherapy","display_name":"neoadjuvant chemotherapy","score":0.9860000014305115},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":0.9259999990463257},{"id":"https://openalex.org/keywords/fdg-pet-ct","display_name":"FDG PET/CT","score":0.8790000081062317},{"id":"https://openalex.org/keywords/early-response-prediction","display_name":"early response prediction","score":0.7459999918937683},{"id":"https://openalex.org/keywords/pathological-complete-response","display_name":"pathological complete response","score":0.9769999980926514},{"id":"https://openalex.org/keywords/anthracycline-cyclophosphamide","display_name":"anthracycline-cyclophosphamide","score":0.9190000295639038},{"id":"https://openalex.org/keywords/taxanes","display_name":"taxanes","score":0.7310000061988831},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.5400000214576721},{"id":"https://openalex.org/keywords/treatment-intensification","display_name":"treatment intensification","score":0.7239999771118164},{"id":"https://openalex.org/keywords/lymph-node-metastasis","display_name":"lymph node metastasis","score":0.503000020980835},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.43700000643730164}],"concepts":[{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.92134690284729},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8862211108207703},{"id":"https://openalex.org/C2780110267","wikidata":"https://www.wikidata.org/wiki/Q7843332","display_name":"Triple-negative breast cancer","level":4,"score":0.6405706405639648},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6270800828933716},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6138796210289001},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.6101288795471191},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.581147313117981},{"id":"https://openalex.org/C2776802502","wikidata":"https://www.wikidata.org/wiki/Q417589","display_name":"Anthracycline","level":4,"score":0.5811415314674377},{"id":"https://openalex.org/C2781190966","wikidata":"https://www.wikidata.org/wiki/Q420436","display_name":"Docetaxel","level":3,"score":0.5571129322052002},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5098296999931335},{"id":"https://openalex.org/C2778292576","wikidata":"https://www.wikidata.org/wiki/Q6991934","display_name":"Neoadjuvant therapy","level":4,"score":0.498126745223999},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4821614623069763},{"id":"https://openalex.org/C2777909004","wikidata":"https://www.wikidata.org/wiki/Q420207","display_name":"Capecitabine","level":4,"score":0.4176611304283142},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.38129112124443054},{"id":"https://openalex.org/C2989005","wikidata":"https://www.wikidata.org/wiki/Q214963","display_name":"Nuclear medicine","level":1,"score":0.3704965114593506},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.12032550573348999},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs21-p2-12-07","doi":"https://doi.org/10.1158/1538-7445.sabcs21-p2-12-07","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs21-p2-12-07","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W1966763768","https://openalex.org/W2234482261","https://openalex.org/W4386045768","https://openalex.org/W1918122136","https://openalex.org/W4405560439","https://openalex.org/W3021282145","https://openalex.org/W7166491525","https://openalex.org/W7158001117","https://openalex.org/W2145191585","https://openalex.org/W2093651547"],"abstract_inverted_index":{"Abstract":[0],"Introduction.":[1],"The":[2,53,455],"addition":[3,531],"of":[4,38,55,64,76,118,132,142,158,203,206,229,277,287,314,330,344,373,407,416,464,532,537],"carboplatin":[5,215,441,452,533],"to":[6,48,59,238,250],"standard":[7],"neoadjuvant":[8,99,127,272,426,528],"chemotherapy":[9,100,331,450,529],"(NAC)":[10,101],"including":[11],"dose-dense":[12],"(dd)":[13],"anthracycline-cyclophosphamide":[14],"(AC)":[15],"combination":[16],"followed":[17,210],"by":[18,211,259,459],"taxanes":[19],"in":[20,79,107,149,162,186,253,279,289,302,308,325,347,354,424,447,475],"triple":[21,524],"negative":[22,387,396,525],"breast":[23,280,309,326,355,526],"cancer":[24,527],"(TNBC)":[25],"is":[26,442],"the":[27,61,130,405,460,538],"most":[28],"intense":[29],"routinely":[30],"used":[31,249],"approach,":[32],"not":[33,138,431],"widely":[34],"accepted":[35],"and":[36,85,90,113,161,336,359,380,395,466,473,481],"potentially":[37],"increased":[39],"toxicity.":[40],"Fluorodeoxyglucose":[41],"PET/CT":[42,180,193,519],"ealy":[43],"response":[44,70,446,521],"assessment":[45],"may":[46],"aid":[47],"decide":[49],"about":[50],"treatment":[51,128,152,160,231],"intensification.":[52],"aim":[54],"our":[56,108],"study":[57,181,198,456],"was":[58,153,166,184,235,248,257,281,292,305,316,332,337,350,360,409,457],"define":[60],"optimal":[62,376],"cut-off":[63,372],"SUVmax":[65,278,288,301,315,323,370,417],"decrease":[66,324,343,371,415,429],"for":[67,339,404,478,523],"pathological":[68],"complete":[69],"(pCR)":[71],"prediction":[72,369,406,522],"after":[73,200,271,327],"one":[74,163,328],"cycle":[75,202,329],"AC":[77,84],"regimen,":[78],"patients":[80,93,124,136,151,173,190,207,267,298],"who":[81],"received":[82,208,226],"further":[83],"taxane":[86],"plus":[87,213,219],"carboplatin.":[88,221],"Material":[89],"Methods.":[91],"122":[92],"with":[94,146,223,318,363,382,440,451,530],"TNBC":[95,425],"were":[96,174],"enrolled":[97,175],"into":[98,176],"within":[102],"STRATEGMED":[103,486],"2/267398/4/NCBR/2015":[104],"research":[105],"project":[106,469],"center":[109],"between":[110,378],"Jan":[111],"2018":[112],"Dec":[114,546],"2020,":[115],"upon":[116],"approval":[117],"Ethics":[119],"Commitee.":[120],"Among":[121],"them":[122],"15":[123],"still":[125],"continued":[126],"at":[129],"time":[131],"data":[133],"cut-off,":[134],"3":[135],"did":[137],"receive":[139],"anthracyclines":[140],"because":[141],"lifetime":[143],"cumulative":[144],"dose":[145],"previous":[147],"treatments,":[148],"2":[150],"interrupted":[154],"during":[155],"first":[156],"cycles":[157,228],"anthracycline-based":[159],"patient":[164],"there":[165],"no":[167],"evident":[168],"(18)F-fluorodeoxyglucose":[169],"uptake.":[170],"Remaining":[171],"101":[172],"this":[177],"study.":[178],"Baseline":[179],"before":[182,242],"NAC":[183],"performed":[185,199,236],"all":[187],"patients,":[188],"73":[189],"had":[191],"baseline":[192,300,312],"as":[194,196],"well":[195],"additional":[197],"1st":[201],"chemotherapy.":[204,273],"Majority":[205],"ddAC":[209],"docetaxel":[212],"every-three-week":[214],"or":[216,241],"weekly":[217,220],"paclitaxel":[218],"Patients":[222],"residual":[224],"disease":[225],"8":[227],"capecitabine":[230,243],"adjuvantly.":[232],"Radiation":[233],"therapy":[234,477],"according":[237],"guidelines,":[239],"concurrently":[240],"treatment.":[244],"Mann-Whitney":[245],"U":[246],"test":[247],"assess":[251],"differences":[252],"variables,":[254],"predictive":[255,338,392,397],"value":[256,313,393,398],"evaluated":[258],"receiver-operating":[260],"characteristic":[261],"(ROC)":[262],"curve":[263],"analysis.":[264],"Results.":[265],"54":[266],"(53,5%)":[268],"achieved":[269],"pCR":[270,319,340,364,368,408,422,433],"At":[274],"baseline,":[275],"median":[276,286],"10.2":[282],"(IQR":[283,294,334],"7.2-14.4),":[284],"whereas":[285],"lymph":[290,303,348],"nodes":[291,304,349],"3.7":[293],"0-10.0).":[295],"In":[296],"16":[297],"(16%)":[299],"higher":[306],"than":[307,353],"(ratio>1).":[310],"Higher":[311],"associated":[317,362],"achievement":[320,365],"(p=0.037).":[321],"Median":[322,342],"33%":[333],"11%-52%)":[335],"(p=0.000021).":[341],"18-FDG":[345],"uptake":[346],"more":[351],"pronounced":[352],"(53%;":[356],"IQR":[357],"29%-84%)":[358],"also":[361],"(p=0.012).":[366],"For":[367],"40%":[374],"provided":[375],"trade-off":[377],"sensitivity":[379],"specificity,":[381],"positive":[383,391],"likelihood":[384,388],"ratio":[385,389],"2.35,":[386],"0.33,":[390],"80%":[394],"64%.":[399],"By":[400],"ROC":[401],"analysis,":[402],"AUC":[403],"0.7604":[410],"(p=0.036).":[411],"Conclusions.":[412],"While":[413],"high":[414,421],"relatively":[418],"strongly":[419],"indicates":[420],"chance":[423],"chemotherapy,":[427],"lower":[428],"does":[430],"preclude":[432],"occurrence":[434],"when":[435],"intensive":[436],"four-drug":[437],"sequential":[438],"regimen":[439],"used.":[443],"Studies":[444],"assessing":[445],"reverse":[448],"sequence":[449],"are":[453],"warranted.":[454],"supported":[458],"Polish":[461],"National":[462],"Center":[463],"Research":[465],"Development":[467],"MILESTONE":[468],"-":[470],"Molecular":[471],"diagnostics":[472],"imaging":[474],"individualized":[476],"breast,":[479],"thyroid":[480],"prostate":[482],"cancer,":[483],"grant":[484],"no.":[485],"2/267398/4/NCBR/2015.":[487],"Citation":[488],"Format:":[489],"Marcin":[490],"Kubeczko,":[491],"Anna":[492,496],"Michalik,":[493],"Agnieszka":[494,508],"Badora-Rybicka,":[495],"Polakiewicz-Gilowska,":[497],"Andrea":[498],"d'Amico,":[499],"Micha\u0142":[500,516],"Kalemba,":[501],"Aleksandra":[502],"Le\u015bniak,":[503],"Katarzyna":[504],"\u015awiderska,":[505],"Marta":[506],"Mianowska-Malec,":[507],"Pasierbek,":[509],"Barbara":[510,514],"\u0141anoszka,":[511],"Konstanty":[512],"Chomik,":[513],"Bobek-Billewicz,":[515],"Jarz\u0105b.":[517],"Fdg":[518],"early":[520],"[abstract].":[534],"In:":[535],"Proceedings":[536],"2021":[539,545],"San":[540,548],"Antonio":[541],"Breast":[542],"Cancer":[543,554],"Symposium;":[544],"7-10;":[547],"Antonio,":[549],"TX.":[550],"Philadelphia":[551],"(PA):":[552],"AACR;":[553],"Res":[555],"2022;82(4":[556],"Suppl):Abstract":[557],"nr":[558],"P2-12-07.":[559]},"counts_by_year":[],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2022-04-03T00:00:00"}